Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Integra Therapeutics has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Integra Therapeutics's investors include Columbus Venture Partners, European Innovation Council Fund, Invivo Capital Partners, AdBio partners, CDTI Innovación's INNVIERTE program.
Integra Therapeutics is headquartered in Barcelona, Spain.
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Integra Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Integra Therapeutics — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/integra-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Integra Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/integra-therapeutics
{{cite web |title=Integra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/integra-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated